Two-year efficacy, safety, and drug survival of dupilumab for atopic dermatitis: A real-world Canadian multicenter retrospective study

被引：16
|
作者：
Georgakopoulos, Jorge R. [1 ]
Felfeli, Tina [2 ,3 ]
Drucker, Aaron M. [1 ,3 ,4 ]
Jo, Christine E. [5 ]
Piguet, Vincent [1 ,4 ]
Yeung, Jensen [1 ,6 ,7 ,8 ]
机构：
[1] Univ Toronto, Dept Med, Div Dermatol, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada
[2] Univ Toronto, Dept Ophthalmol & Vis Sci, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada
[3] Univ Toronto, Inst Hlth Policy Management & Evaluat, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada
[4] Womens Coll Hosp, Toronto, ON, Canada
[5] Univ Ottawa, Fac Med, Ottawa, ON, Canada
[6] Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada
[7] Prob Med Res Inc, Waterloo, ON, Canada
[8] Womens Coll Hosp, Dept Dermatol, 76 Grenville St,Fifth Floor, Toronto, ON M5S 1B2, Canada
来源：
JAAD INTERNATIONAL | 2021年 / 4卷
关键词：
adverse event; atopic dermatitis; drug survival; dupilumab; efficacy; safety;
D O I：
10.1016/j.jdin.2021.06.001
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
下载
收藏
页码：67 / 69
页数：3
相关论文
共 50 条
  • [21] Real-world response to dupilumab in patients with atopic dermatitis: a retrospective review of 100 patients
    Bajwa, D.
    Worthy, O.
    Griffiths, S.
    Hussain, A.
    Ball, S.
    Meggitt, S.
    Reynolds, N.
    Hampton, P.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 : 64 - 64
  • [22] Real-world effectiveness and safety of dupilumab for the treatment of moderate to severe atopic dermatitis in Indian patients: A multi centric retrospective study
    Dhar, Sandipan
    De, Abhishek
    Srinivas, Sahana M.
    INDIAN JOURNAL OF DERMATOLOGY, 2021, 66 (03) : 297 - 301
  • [23] Real-world effectiveness and safety of dupilumab in patients with moderate and severe atopic dermatitis: 2-year experience
    Fujiwara, Chisako
    Uchiyama, Akihiko
    Inoue, Yuta
    Ishikawa, Mai
    Motegi, Sei-ichiro
    JOURNAL OF CUTANEOUS IMMUNOLOGY AND ALLERGY, 2023, 6 (03) : 88 - 93
  • [24] One-year real-world clinical effectiveness, safety, and laboratory safety of dupilumab in Japanese adult patients with atopic dermatitis: A single-center retrospective study
    Uchida, Hideaki
    Kamata, Masahiro
    Kato, Aika
    Mizukawa, Itsumi
    Watanabe, Ayu
    Agematsu, Ai
    Nagata, Mayumi
    Fukaya, Saki
    Hayashi, Kotaro
    Fukuyasu, Atsuko
    Tanaka, Takamitsu
    Ishikawa, Takeko
    Ohnishi, Takamitsu
    Tada, Yayoi
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 84 (02) : 547 - 550
  • [25] TREATGermany registry: "real-world effectiveness" of dupilumab in atopic dermatitis
    Weidinger, S.
    Stoelzl, D.
    Abraham, S.
    Haufe, E.
    Heratizadeh, A.
    Werfel, T.
    Schmitt, J.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (09) : S236 - S236
  • [26] Real-world persistence with dupilumab among adults with atopic dermatitis
    Silverberg, Jonathan I.
    Guttman-Yassky, Emma
    Gadkari, Abhijit
    Kuznik, Andreas
    Mallya, Usha G.
    Mastey, Vera
    Zhang, Haixin
    Chen, Zhen
    Chen, Cheng
    Korotzer, Andrew
    Sierka, Debra
    Fenton, Miriam C.
    Kaur, Mandeep
    Jalbert, Jessica J.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 126 (01) : 40 - 45
  • [27] Real-world effectiveness and safety of upadacitinib in Japanese patients with atopic dermatitis: a two-centre retrospective study
    Kosaka, Keiji
    Uchiyama, Akihiko
    Ishikawa, Mai
    Watanabe, Goichi
    Motegi, Sei-ichiro
    EUROPEAN JOURNAL OF DERMATOLOGY, 2022, 32 (06) : 800 - 802
  • [28] Real-world effectiveness and safety of upadacitinib in Japanese patients with atopic dermatitis: a two-centre retrospective study
    Keiji Kosaka
    Akihiko Uchiyama
    Mai Ishikawa
    Goichi Watanabe
    Sei-ichiro Motegi
    European Journal of Dermatology, 2022, 32 : 800 - 802
  • [29] Effectiveness and Safety of Dupilumab in Children Under 6 Years of Age with Moderate-to-Severe Atopic Dermatitis: A Retrospective Real-World Study
    Berna-Rico, Emilio
    Fiz-Benito, Esther
    Busto-Leis, Jose Manuel
    Servera-Negre, Guillermo
    de Lucas-Laguna, Raul
    Feito-Rodriguez, Marta
    DERMATOLOGY, 2024, 240 (02) : 337 - 342
  • [30] Effectiveness and safety of dupilumab in moderate-to-severe atopic dermatitis patients with chronic renal insufficiency: a real-world retrospective study in China
    Peng, Cong
    Cao, Qiaozhi
    Xiong, Feng
    Xu, Hui
    Li, Jie
    MEDCOMM, 2024, 5 (10):
12345